Quest Diagnostics logo

Quest Diagnostics

DGX | NYSE
Chart Builder DCF Calculator
$231.97
-$12.91 (-5.27%)
Sep 22, 2026, 11:13 AM ET · Market open
-5.27%

Rating

Updated: Aug 31, 2026
34.8
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow

Key Statistics

Market Data

Market Cap $25.6B
1D Range
227.24 236.81
52W Range
171.18 248.84

Valuation (TTM)

PE 26
PB 3.60
EV/EBITDA 16.33

Valuation (NTM)

Forward PE 20.17
Forward PEG 3.32
Price Target $248.57
Loading financial charts...

Profile

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestic...

Sector Healthcare
Employees 51,500
IPO Date Dec 16, 1996
Fiscal Year January - December

Latest News

5 hours ago · zacks.com

Is This the Right Time to Add DGX Stock to Your Portfolio?

1 day ago · marketbeat.com

Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges

1 day ago · prnewswire.com

Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?

6 days ago · zacks.com

Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics

6 days ago · prnewswire.com

Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript

7 days ago · seekingalpha.com

Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript
Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?

8 days ago · zacks.com

Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?

22 days ago · zacks.com

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com

28 days ago · prnewswire.com

Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
Is it the Right Time to Retain DGX Stock in Your Portfolio?

1 month ago · zacks.com

Is it the Right Time to Retain DGX Stock in Your Portfolio?

Earnings

Next Earnings
Oct 20, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
11
Consensus
Hold
Price Target
$250
Upside
+7.77%
Buy (4)
Hold (6)
Sell (0)
Analyst Details

© 2026 bestshares.com. All rights reserved.